Auxilium Pharmaceuticals Inc (AUXL) financial statements (2021 and earlier)

Company profile

Business Address 640 LEE ROAD
CHESTERBROOK, PA 19087
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7845777112175468
Cash and cash equivalents742556489130336
Short-term investments42020233045132
Receivables82549589747648
Inventory, net of allowances, customer advances and progress billings57544742454024
Inventory57544742454024
Prepaid expense and other current assets10104
Deferred tax assets15151515   
Other undisclosed current assets31251021522
Total current assets:262192244239255202546
Noncurrent Assets
Inventory, Noncurrent57576355545849
Property, plant and equipment34363635363734
Intangible assets, net (including goodwill)775811834854764769
Goodwill9898104104123113 
Intangible assets, net (excluding goodwill)677713730749641656 
Other noncurrent assets17181919   
Prepaid expense and other noncurrent assets192014
Total noncurrent assets:88392395296387388496
TOTAL ASSETS:1,1451,1151,1961,2011,1281,086643
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities16214916814314813796
Accounts payable25819110103
Accrued liabilities11512413512212011183
Employee-related liabilities2317142019179
Debt171414141510 
Deferred revenue and credits4433347
Deferred tax liabilities    1111 
Other undisclosed current liabilities25285536(1)8(9)
Total current liabilities:20819424019617517093
Noncurrent Liabilities
Long-term debt and lease obligation278236239242243201 
Long-term debt, excluding current maturities278236239242243201 
Liabilities, other than long-term debt61555656434332
Deferred revenue and credits38313232333232
Deferred tax liabilities, net242424241111 
Other undisclosed noncurrent liabilities435451451456383365 
Total noncurrent liabilities:77574274675367060932
Total liabilities:983936986950845779125
Stockholders' equity
Stockholders' equity attributable to parent, including:162179210251283307232
Treasury stock, value(5)(4)(4)(3)(3)(3)(3)
Additional paid in capital631616611595589583565
Accumulated other comprehensive loss(0)(0)(0)(0)(0)(0)(0)
Accumulated deficit(465)(433)(396)(340)(302)(273)(330)
Other undisclosed stockholders' equity attributable to parent1110000
Total stockholders' equity:162179210251283307232
Other undisclosed liabilities and equity      285
TOTAL LIABILITIES AND EQUITY:1,1451,1151,1961,2011,1281,086643

Income statement (P&L) ($ in millions)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Revenues
(Revenue, Net)
110838912610810166
Cost of revenue(26)(37)(22)(36)(38)(29)(15)
Cost of goods and services sold(26)(37)(18)(36)(34)(27)(15)
Gross profit:84466790707151
Operating expenses(120)(100)(113)(104)(90)(99)(58)
Other undisclosed operating income (loss)1327 (1)  2
Operating loss:(23)(27)(46)(15)(20)(28)(5)
Nonoperating income (expense)00(0)000(0)
Investment income, nonoperating      (0)
Other nonoperating income (expense)00(0)000 
Interest and debt expense(10)(10)(10)(10)(9)(7)(3)
Loss from continuing operations before income taxes:(33)(37)(56)(24)(29)(35)(8)
Income tax expense (benefit)00(0)(14)(0)92 
Net income (loss) available to common stockholders, diluted:(33)(36)(56)(38)(29)57(8)

Comprehensive Income ($ in millions)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Net income (loss):(33)(36)(56)(38)(29)57(8)
Comprehensive income (loss):(33)(36)(56)(38)(29)57(8)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)000(0)0
Comprehensive income (loss), net of tax, attributable to parent:(32)(36)(56)(38)(29)57(8)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: